| Sep 11, 2026Latest represented filing date | GILEAD SCIENCES, INC. (GILD)Nasdaq | Current covered snapshotChairman & CEO · DirectorValuation observation Sep 25, 2026 | Common Stock, par value, $0.001 per share: 581,683 sharesCurrent covered company value: $87.76M | Published current ownership snapshotForms represented: 4Owner filingsIssuer filings |
| Sep 11, 2026Filed date | GILEAD SCIENCES, INC. (GILD)Nasdaq | AcquisitionSEC code MEffective Sep 10, 2026 · transaction dateReported units 8,780 shares · reported price not provided | Common Stock, par value, $0.001 per shareReported position after transaction: 585,913 shares | 4 filing0001638643-26-000033 |
| Sep 11, 2026Filed date | GILEAD SCIENCES, INC. (GILD)Nasdaq | DispositionSEC code FEffective Sep 10, 2026 · transaction dateReported units 4,230 shares · reported price 144.81 | Common Stock, par value, $0.001 per shareReported position after transaction: 581,683 shares | 4 filing0001638643-26-000033 |
| Sep 2, 2026Filed date | GILEAD SCIENCES, INC. (GILD)Nasdaq | SaleSEC code SEffective Sep 1, 2026 · transaction dateReported units 1,600 shares · reported price 147.5087 | Common Stock, par value, $0.001 per shareReported position after transaction: 590,533 shares | 4 filing0001638643-26-000031 |
| Sep 2, 2026Filed date | GILEAD SCIENCES, INC. (GILD)Nasdaq | SaleSEC code SEffective Sep 1, 2026 · transaction dateReported units 7,992 shares · reported price 148.3636 | Common Stock, par value, $0.001 per shareReported position after transaction: 582,541 shares | 4 filing0001638643-26-000031 |
| Sep 2, 2026Filed date | GILEAD SCIENCES, INC. (GILD)Nasdaq | SaleSEC code SEffective Sep 1, 2026 · transaction dateReported units 5,408 shares · reported price 149.3817 | Common Stock, par value, $0.001 per shareReported position after transaction: 577,133 shares | 4 filing0001638643-26-000031 |
| Aug 4, 2026Filed date | GILEAD SCIENCES, INC. (GILD)Nasdaq | SaleSEC code SEffective Aug 3, 2026 · transaction dateReported units 6,700 shares · reported price 129.6583 | Common Stock, par value, $0.001 per shareReported position after transaction: 600,433 shares | 4 filing0001638643-26-000028 |
| Aug 4, 2026Filed date | GILEAD SCIENCES, INC. (GILD)Nasdaq | SaleSEC code SEffective Aug 3, 2026 · transaction dateReported units 7,700 shares · reported price 130.8022 | Common Stock, par value, $0.001 per shareReported position after transaction: 592,733 shares | 4 filing0001638643-26-000028 |
| Aug 4, 2026Filed date | GILEAD SCIENCES, INC. (GILD)Nasdaq | SaleSEC code SEffective Aug 3, 2026 · transaction dateReported units 600 shares · reported price 131.3433 | Common Stock, par value, $0.001 per shareReported position after transaction: 592,133 shares | 4 filing0001638643-26-000028 |
| Jul 2, 2026Filed date | GILEAD SCIENCES, INC. (GILD)Nasdaq | SaleSEC code SEffective Jul 1, 2026 · transaction dateReported units 11,900 shares · reported price 126.0897 | Common Stock, par value, $0.001 per shareReported position after transaction: 610,233 shares | 4 filing0001638643-26-000026 |
| Jul 2, 2026Filed date | GILEAD SCIENCES, INC. (GILD)Nasdaq | SaleSEC code SEffective Jul 1, 2026 · transaction dateReported units 3,100 shares · reported price 127.075 | Common Stock, par value, $0.001 per shareReported position after transaction: 607,133 shares | 4 filing0001638643-26-000026 |